An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer
- 1 October 1999
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (10), 1721-1727
- https://doi.org/10.1038/sj.gt.3301001
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 42 references indexed in Scilit:
- Cell-specific promoter in adenovirus vector for transgenic expression of SERCA1 ATPase in cardiac myocytesAmerican Journal of Physiology-Cell Physiology, 1998
- In VivoTherapy of Hepatocellular Carcinoma with a Tumor-Specific Adenoviral Vector Expressing Interleukin-2Human Gene Therapy, 1997
- Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promotersCardiovascular Research, 1997
- Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo.Journal of Clinical Investigation, 1997
- Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancerGene Therapy, 1997
- The Pancreatitis-associated Protein I Promoter Allows Targeting to the Pancreas of a Foreign Gene, Whose Expression Is Up-regulated during Pancreatic InflammationPublished by Elsevier ,1997
- Hypoxia Regulates Vascular Endothelial Growth Factor Gene Expression in Endothelial CellsCirculation Research, 1995
- Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer.Proceedings of the National Academy of Sciences, 1994
- Functional analysis of an oxygen-regulated transcriptional enhancer lying 3' to the mouse erythropoietin gene.Proceedings of the National Academy of Sciences, 1991
- Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene.Proceedings of the National Academy of Sciences, 1991